IFT122P3: A Potential Drug Target and Biomarker (G653712)

Target Name: IFT122P3

NCBI ID: G653712

IFT122P3

Other Name(s): IFT122 pseudogene 3

IFT122P3: A Potential Drug Target and Biomarker

Introduction

The IFT122P3 gene, also known as IFT122P3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is located on chromosome 16 and encodes a protein known as IFT122P3, which is involved in the regulation of cell adhesion and migration. The IFT122P3 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Disease-related functions of IFT122P3

IFT122P3 is involved in the regulation of cell adhesion and migration, which are essential processes that play a crucial role in the development and progression of diseases. IFT122P3 has been shown to promote the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain tissue structure and prevent excessive fluid leakage. In addition, IFT122P3 has been shown to regulate the migration of cells, which is critical for the development of tissues and organs during development and embryonic development.

IFT122P3 is also involved in the regulation of cell signaling pathways that are critical for the growth, survival, and progression of tissues. For example, IFT122P3 has been shown to regulate theNotch signaling pathway, which is involved in the regulation of cell proliferation and survival. In addition, IFT122P3 has been shown to regulate the TGF-β signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival.

IFT122P3 as a potential drug target

The IFT122P3 gene has been identified as a potential drug target due to its involvement in the regulation of cell signaling pathways that are critical for the development and progression of diseases. In addition, IFT122P3 has been shown to interact with various drug targets, including the tyrosine kinase FAK, which is involved in the regulation of cell signaling pathways that are critical for the development and progression of diseases.

IFT122P3 has also been shown to play a role in the regulation of cancer cell proliferation and survival. For example, studies have shown that IFT122P3 is involved in the regulation of the growth and survival of cancer cells, which is critical for the development and progression of cancer. In addition, IFT122P3 has been shown to regulate the angiogenesis of cancer cells, which is the process by which cancer cells develop into tumors.

IFT122P3 as a biomarker

IFT122P3 has also been identified as a potential biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that IFT122P3 is involved in the regulation of cell adhesion and migration, which are critical processes that play a crucial role in the development and progression of diseases. In addition, IFT122P3 has been shown to regulate the growth and survival of cancer cells, which is critical for the development and progression of cancer.

IFT122P3 has also been shown to be involved in the regulation of cell signaling pathways that are critical for the growth, survival, and progression of tissues. For example, IFT122P3 has also been shown to regulate theNotch signaling pathway, which is involved in the regulation of cell proliferation and survival. In addition, IFT122P3 has been shown to regulate the TGF-β signaling pathway,

Protein Name: IFT122 Pseudogene 3

The "IFT122P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFT122P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets